The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial

CONCLUSION: This trial informs safety concerns related to use of live virus vaccines in patients receiving biologics.PRIMARY FUNDING SOURCE: The National Institute of Arthritis and Musculoskeletal and Skin Diseases and the American College of Rheumatology.PMID:34570596 | DOI:10.7326/M20-6928

Source: Annals of Internal Medicine - September 27, 2021 Category: Internal Medicine Authors: Jeffrey R Curtis Stacey S Cofield S Louis Bridges John Bassler Atul Deodhar Theresa L Ford Joseph Huffstutter Allen Jankeel Alan Kivitz Shaila Kamal Stephen Lindsey Ilhem Messaoudi Norma Mendoza Kaleb Michaud Ted R Mikuls David Ridley William Shergy Sarah Source Type: research